Encapsula NanoSciences LLC – Trademark Portfolio
Entity Type: 16
Encapsula NanoSciences LLC holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 10 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include DOXOSOME, GENESOME, ENCAPSOME, CLODROSOME, and MAGNETOSOME. The owner is based in Brentwood, TN.
5409 Maryland Way, Suite 360
Brentwood, TN 37027
Showing of trademarks Trademarks
Trademark Classifications
Encapsula NanoSciences LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Encapsula NanoSciences LLC have?
Encapsula NanoSciences LLC has 14 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 abandoned, 6 cancelled.
What trademark classes does Encapsula NanoSciences LLC file in?
Encapsula NanoSciences LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Encapsula NanoSciences LLC's most well-known trademarks?
Encapsula NanoSciences LLC's registered trademark portfolio includes well-known marks such as DOXOSOME, GENESOME, ENCAPSOME, CLODROSOME, and MAGNETOSOME. These are among 6 currently registered trademarks in the portfolio.
What is Encapsula NanoSciences LLC's trademark registration success rate?
Encapsula NanoSciences LLC has a 43% trademark registration rate, with 6 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.